Published in Proteomics Clin Appl on November 11, 2010
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides. J Am Soc Nephrol (2015) 1.05
Biomarkers in development of psychotropic drugs. Dialogues Clin Neurosci (2011) 0.89
Proteomics of vitreous humor of patients with exudative age-related macular degeneration. PLoS One (2014) 0.85
Proteomic urinary biomarker approach in renal disease: from discovery to implementation. Pediatr Nephrol (2014) 0.85
Ultrasensitive sample quantitation via selected reaction monitoring using CITP/CZE-ESI-triple quadrupole MS. Anal Chem (2012) 0.82
Identification of urinary peptide biomarkers associated with rheumatoid arthritis. PLoS One (2014) 0.82
Protein interactome of muscle invasive bladder cancer. PLoS One (2015) 0.82
Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry. Anal Chem (2014) 0.81
Identification of ageing-associated naturally occurring peptides in human urine. Oncotarget (2015) 0.80
Capillary zone electrophoresis for bottom-up analysis of complex proteomes. Proteomics (2015) 0.80
Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment. Sleep Sci (2015) 0.77
BcCluster: A Bladder Cancer Database at the Molecular Level. Bladder Cancer (2016) 0.76
Identification of Symptomatic Fetuses Infected with Cytomegalovirus Using Amniotic Fluid Peptide Biomarkers. PLoS Pathog (2016) 0.76
Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models. Br J Cancer (2015) 0.75
The use of urinary proteomics in the assessment of suitability of mouse models for ageing. PLoS One (2017) 0.75
Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products. PLoS One (2013) 0.75
Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion. PLoS One (2016) 0.75
Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physicians. ISRN Endocrinol (2012) 0.75
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res (2008) 2.12
Urine in clinical proteomics. Mol Cell Proteomics (2008) 2.05
Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol (2007) 1.56
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med (2006) 1.52
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res (2007) 1.52
LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol (2007) 1.51
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48
Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease. Circ Cardiovasc Genet (2014) 1.44
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev (2009) 1.19
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin Appl (2007) 1.17
Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics (2010) 1.16
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl (2010) 1.12
The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics (2009) 1.11
Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta (2008) 1.04
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy. Proteomics Clin Appl (2008) 1.01
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol (2010) 0.99
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes (2008) 0.96
Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opin Investig Drugs (2011) 0.94
Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment. Circulation (2002) 0.90
A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem (2002) 0.90
Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol (2008) 0.90
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. PLoS One (2013) 0.90
Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol (2002) 0.89
Clinical proteomics in obstetrics and neonatology. Expert Rev Proteomics (2014) 0.88
Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis (2010) 0.88
Non-invasive markers of ureteropelvic junction obstruction. World J Urol (2007) 0.88
Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med (2013) 0.87
The KUPKB: a novel Web application to access multiomics data on kidney disease. FASEB J (2012) 0.87
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol (2009) 0.87
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments. Anal Bioanal Chem (2008) 0.87
Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem (2006) 0.86
Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor. Biochem Biophys Res Commun (2009) 0.85
Systems biology: opening new avenues in clinical research. Nephrol Dial Transplant (2010) 0.84
Renal fibrosis: insight from proteomics in animal models and human disease. Proteomics (2011) 0.84
Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages. Am J Physiol Renal Physiol (2012) 0.84
Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis. Pancreas (2016) 0.84
Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis. Exp Biol Med (Maywood) (2009) 0.84
Renal tubular fluid shear stress promotes endothelial cell activation. Biochem Biophys Res Commun (2011) 0.83
Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int (2002) 0.82
Bradykinin and renal fibrosis: have we ACE'd it? J Am Soc Nephrol (2004) 0.81
Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene. Regul Pept (2007) 0.81
[Bradykinin receptors: towards new pathophysiological roles]. Med Sci (Paris) (2003) 0.81
miRNAs in urine: a mirror image of kidney disease? Expert Rev Mol Diagn (2015) 0.80
Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction. Regul Pept (2007) 0.80
Hnf-1β transcription factor is an early hif-1α-independent marker of epithelial hypoxia and controls renal repair. PLoS One (2013) 0.80
Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes. Biol Chem (2006) 0.79
Systems biology to battle vascular disease. Nephrol Dial Transplant (2010) 0.78
Renal and urinary proteomics. Proteomics Clin Appl (2011) 0.78
The KUPNetViz: a biological network viewer for multiple -omics datasets in kidney diseases. BMC Bioinformatics (2013) 0.77
Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin. Nephrol Dial Transplant (2010) 0.77
Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications. Bioanalysis (2014) 0.77
Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling. J Urol (2012) 0.77
Transcriptional regulation of the rat bradykinin B2 receptor gene: identification of a silencer element. Mol Pharmacol (2002) 0.76
Molecular structure and transcriptional regulation by nuclear factor-kappaB of the mouse kinin B1 receptor gene. Biol Chem (2005) 0.76
Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment. Proteomics (2013) 0.76
[Renal urinary shear stress: a novel actor in nephropathies]. Med Sci (Paris) (2013) 0.76
Direct protein-protein interaction between PLCgamma1 and the bradykinin B2 receptor--importance of growth conditions. Biochem Biophys Res Commun (2005) 0.76
Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products. PLoS One (2013) 0.75
[Tubulo-interstitial fibrosis: an emerging major health problem]. Med Sci (Paris) (2011) 0.75
Is the time ripe for kidney tissue proteomics? Proteomics Clin Appl (2011) 0.75